Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

ObsEva SA (OBSV)

3.48   0.06 (1.75%) 02-14 16:00
Open: 3.45 Pre. Close: 3.42
High: 3.53 Low: 3.37
Volume: 365,975 Market Cap: 152M
ObsEva SA is a clinical stage biopharmaceutical company. It is engaged in the development and commercialization of novel therapeutics for serious conditions that comprise a woman's reproductive health and pregnancy.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.533 - 3.558 3.558 - 3.577
Low: 3.325 - 3.35 3.35 - 3.37
Close: 3.446 - 3.486 3.486 - 3.518

Technical analysis

as of: 2020-02-14 4:31:17 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.88     One year: 5.47
Support: Support1: 3.37    Support2: 2.80
Resistance: Resistance1: 4.18    Resistance2: 4.68
Pivot: 3.66
Moving Average: MA(5): 3.52     MA(20): 3.79
MA(100): 4.91     MA(250): 8.83
MACD: MACD(12,26): -0.09     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 9.30     %D(3): 7.82
RSI: RSI(14): 43.56
52-week: High: 14.50  Low: 2.38  Change(%): -71.0
Average Vol(K): 3-Month: 109186  10-Days: 63550

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
OBSV has closed above bottom band by 18.3%. Bollinger Bands are 77.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to OBSV's normal range. The bands have been in this narrow range for 32 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

ObsEva and Selecta Bio up premarket on bullish ratings
ObsEva (NASDAQ:OBSV) initiated with Buy rating and $19 (395% upside) price target at Kempen & Co. Shares up 8% premarket. Selecta Biosciences (NASDAQ:SELB)

ObsEva's Menstrual Bleeding Drug Produces 'Best-In-Class' Response In Late-Stage Study
Swiss biopharma Obseva SA (NASDAQ: OBSV ), which is developing orally administered, clinical-stage compounds to treat women's reproductive health conditions, announced a positive late-stage clinical readout Monday for its investigational compound to treat heavy menstrual bleeding due to uterine fibroids. ObsEva saw its shares a decline steeply in early November due to a failed trial of nolasiban, another pipeline asset. ObsEva's Study Results The Phase 3 study dubbed PRIMROSE 2 met the primary and secondary efficacy endpoints, ObsEva said. The study evaluated once-daily oral linzagolix in 100mg and 200mg doses, with and without hormonal add-back therapy, or ABT, The primary efficacy endpoint was the reduction in heavy menstrual bleeding. The responder rate was 93.9% for women receiving 200mg linzagolix with ABT and 56.7% for women receiving 100mg without ABT versus 29.4% for the placebo group. The company termed the response for the 200mg dose as "best-in-class." Both doses achieved significant rates of amenorrhea, reduction …

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 43.80
Shares Float (M) 11.72
% Held by Insiders 7.13
% Held by Institutions 74.15
Shares Short (K) 703
Shares Short P. Month (K)

Stock Financials

EPS -2.480
Book Value (p.s.) 1.590
PEG Ratio
Profit Margin
Operating Margin -667125.00
Return on Assets (ttm) -43.3
Return on Equity (ttm) -92.2
Qtrly Rev. Growth 150.0
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.424
Qtrly Earnings Growth
Operating Cash Flow (M) -85.09
Levered Free Cash Flow (M) -50.84

Stock Valuations

P/E -1.40
P/E Growth Ratio 0.02
P/BV 2.19
P/CF -1.79

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.